Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters

Overview of attention for article published in International Journal of Pharmaceutics, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 8,393)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 16 news stories from 13 outlets.

Complete Safety Data Anticipated by End of 1Q 2022 Safety Management Committee Has Recommended 12 mg as Phase 2 Dose…

GlobeNewswire 2022-01-27 Complete Safety Data Anticipated by End of 1Q 2022 Safety Management Committee Has Recommended 12 mg…

Complete Safety Data Anticipated by End of 1Q 2022 Safety Management Committee Has Recommended 12 mg as Phase 2 Dose…

Complete Safety Data Anticipated by End of 1Q 2022 Safety Management Committee Has Recommended 12 mg as Phase 2 Dose…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 12 additional news stories.